Chairperson of the Board
Elucid
La Jolla, California, United States
Scott is a successful Medtech CEO, Chairperson, board member, entrepreneur, and investor, having been involved in one of those roles in 20+ startup, growth and public companies with market valuations that have totaled over $30b and more importantly over 20 million patients that have benefited from the therapies & diagnostics of these companies, including 8 IPOs. Current professional affiliations include Chairperson Hyperfine (HYPR) IPO 2021, Chairman Envista (NVST) IPO 2019, Exec Chairman Elucid, Exec Chairman On Target Labs, Board member, Q’apel Medical, Board member Proximie, Board member Foldax, & Board member Veranex. Past affilitions include CEO of Verb Surgical (J&J acquisition 2019), Volcano (IPO 2006, Philips acquisition 2015), and Digirad (IPO 2004). He graduated Magna Cum Laude with a BS in Bus Admin from the Univ. of Southern Calif and earned his MBA from the Harvard Business School.
Disclosure information not submitted.
Panel Discussion: What is the future of Software Medical Devices in the Cath Lab?
Monday, March 11, 2024
9:26 AM – 9:45 AM ET
Monday, March 11, 2024
11:46 AM – 12:00 PM ET